Adenomas are benign tumors that arise from glandular tissue. While typically non-cancerous, certain adenomas, particularly those in the colon, can progress to cancer if left untreated. Understanding the molecular mechanisms underlying this progression is crucial in cancer research. Researchers investigate genetic mutations and signaling pathways implicated in adenoma-to-carcinoma progression, aiming to identify biomarkers for early detection and targeted therapies. Advanced imaging techniques and molecular profiling help characterize adenomas and predict their malignant potential. Additionally, studying the tumor microenvironment provides insights into how adenomas interact with surrounding tissues, potentially influencing their transformation into cancer. By elucidating the complexities of adenoma biology, cancer researchers strive to develop more effective prevention and treatment strategies to reduce the burden of adenoma-associated cancers.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : A case-based approach using IMPeTUs criteria in FDG PET/CT reporting of multiple myeloma
Mudalsha Ravina, All India Institute of Medical Sciences, India
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Transforming cancer care: Innovations, integrations, and impact
Shayan Maqsood, Jamia Hamdard University, India
Title : Genetic and epigenetic alterations of SOX7 in multiple myeloma and allied neoplasms
Can Küçük, Dokuz Eylul University, Turkey
Title : Advanced nanoparticles, the hallmark of targeted drug delivery for osteosarcoma
Shayan Maqsood, Jamia Hamdard University, India